The efficacy of the combination of tacrolimus and mycophenolate mofetil for prevention of acute myocardial rejection is dependent on routine monitoring of mycophenolic acid trough acid levels

Transplant Proc. 1999 Feb-Mar;31(1-2):84-7. doi: 10.1016/s0041-1345(98)01448-1.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Clinical Trial, Phase II
  • Comparative Study

MeSH terms

  • Acute Disease
  • Adult
  • Drug Monitoring
  • Drug Therapy, Combination
  • Female
  • Graft Rejection / prevention & control*
  • Heart Transplantation / immunology*
  • Humans
  • Immunosuppressive Agents / blood
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Middle Aged
  • Mycophenolic Acid / analogs & derivatives*
  • Mycophenolic Acid / blood
  • Mycophenolic Acid / therapeutic use
  • Tacrolimus / blood
  • Tacrolimus / therapeutic use*

Substances

  • Immunosuppressive Agents
  • Mycophenolic Acid
  • Tacrolimus